These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36998461)

  • 1. FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy.
    Chen S; Lin J; Zhao J; Lin Q; Liu J; Wang Q; Mui R; Ma L
    Front Oncol; 2023; 13():1147239. PubMed ID: 36998461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.
    Xing L; Xu L; Zhang Y; Che Y; Wang M; Shao Y; Qiu D; Yu H; Zhao F; Zhang J
    Front Oncol; 2022; 12():925041. PubMed ID: 35814468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights and clinical implications for the tumor suppressor role of SCF
    Qi Y; Rezaeian AH; Wang J; Huang D; Chen H; Inuzuka H; Wei W
    Biochim Biophys Acta Rev Cancer; 2024 Jun; 1879(5):189140. PubMed ID: 38909632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development.
    de la Cova CC
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
    Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.
    Hänle-Kreidler S; Richter KT; Hoffmann I
    J Biol Chem; 2022 Dec; 298(12):102703. PubMed ID: 36395886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication.
    Badarudeen B; Gupta R; Nair SV; Chandrasekharan A; Manna TK
    J Biol Chem; 2020 Apr; 295(14):4428-4437. PubMed ID: 32086376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of FBXW7 loss of function in human cancers.
    Fan J; Bellon M; Ju M; Zhao L; Wei M; Fu L; Nicot C
    Mol Cancer; 2022 Mar; 21(1):87. PubMed ID: 35346215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.
    Reiterer V; Figueras-Puig C; Le Guerroue F; Confalonieri S; Vecchi M; Jalapothu D; Kanse SM; Deshaies RJ; Di Fiore PP; Behrends C; Farhan H
    EMBO J; 2017 Feb; 36(3):260-273. PubMed ID: 28007894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXW7 Confers Radiation Survival by Targeting p53 for Degradation.
    Cui D; Xiong X; Shu J; Dai X; Sun Y; Zhao Y
    Cell Rep; 2020 Jan; 30(2):497-509.e4. PubMed ID: 31940492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW7: a critical tumor suppressor of human cancers.
    Yeh CH; Bellon M; Nicot C
    Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent insight into the role of FBXW7 as a tumor suppressor.
    Yumimoto K; Nakayama KI
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCF
    Sugiyama S; Yumimoto K; Inoue I; Nakayama KI
    Genes Cells; 2019 May; 24(5):354-365. PubMed ID: 30838725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
    Onoyama I; Suzuki A; Matsumoto A; Tomita K; Katagiri H; Oike Y; Nakayama K; Nakayama KI
    J Clin Invest; 2011 Jan; 121(1):342-54. PubMed ID: 21123947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
    Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
    J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 in Cancer: What Has Been Unraveled Thus Far?
    Sailo BL; Banik K; Girisa S; Bordoloi D; Fan L; Halim CE; Wang H; Kumar AP; Zheng D; Mao X; Sethi G; Kunnumakkara AB
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30791487
    [No Abstract]   [Full Text] [Related]  

  • 19. Skp1-Cullin-F-box (SCF)-type ubiquitin ligase FBXW7 negatively regulates spermatogonial stem cell self-renewal.
    Kanatsu-Shinohara M; Onoyama I; Nakayama KI; Shinohara T
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8826-31. PubMed ID: 24879440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies.
    Wang W; Jiang K; Liu X; Li J; Zhou W; Wang C; Cui J; Liang T
    Front Pharmacol; 2023; 14():1278056. PubMed ID: 38027013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.